About FDA

Meet Luciana Borio, M.D., Acting Chief Scientist

Luciana Borio, M.D. Dr. Luciana Borio is FDA’s acting chief scientist.  In this capacity, she is responsible for leading and coordinating FDA's cross-cutting scientific and public health efforts.

The Office of the Chief Scientist works closely with FDA’s product centers, providing strategic leadership and support for FDA’s regulatory science and innovation initiatives, including the Advancing Regulatory Science Initiative, the Critical Path Initiative, scientific professional development, scientific integrity, and the Medical Countermeasures Initiative (MCMi).

Since 2011, Dr. Borio has served as the assistant commissioner for counterterrorism policy and director of the Office of Counterterrorism and Emerging Threats (OCET) in the Office of the Chief Scientist at FDA.  In this capacity, Dr. Borio provided leadership, coordination, and oversight for FDA’s national and global health security, counterterrorism, and emerging threat portfolios and led the MCMi.

Dr. Borio has been instrumental in coordinating FDA's response to the 2009 H1N1 influenza pandemic and continues to oversee FDA's preparedness and response activities for emerging threats, such as the avian influenza A (H7N9) virus and the West Africa Ebola epidemic.

Before joining FDA as a medical reviewer in 2008, Dr. Borio served as a senior associate at the University of Pittsburgh Medical Center – Center for Biosecurity, assistant professor of medicine at the University of Pittsburgh, and advisor on biodefense programs for the U.S. Department of Health and Human Services.  Dr. Borio received her M.D. from the George Washington University, and continues to practice medicine at Johns Hopkins Hospital.

 

Page Last Updated: 04/06/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.